/Investor DB

Mount Wilson Ventures — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Cinderbiocinderbio.cominMay 2019

CinderBio develops HTA-Proteases, specialized enzymes for proteomics research that enable comprehensive protein analysis through orthogonal digestion approaches.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBerkeley, US

Jill O Fuss(Executive Officer, Director, Promoter)inSteven M Yannone(Executive Officer, Director, Promoter)in

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.